Interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-10	I-protein
inhibits	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF	B-protein
kappa	I-protein
B	I-protein
)	O
activation	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

IL-10	B-protein
and	O
IL-4	B-protein
suppress	O
cytokine	B-protein
synthesis	O
by	O
different	O
mechanisms	O
.	O

Our	O
previous	O
studies	O
in	O
human	B-cell_type
monocytes	I-cell_type
have	O
demonstrated	O
that	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-10	I-protein
inhibits	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-stimulated	O
production	O
of	O
inflammatory	B-protein
cytokines	I-protein
,	O
IL-1	B-protein
beta	I-protein
,	O
IL-6	B-protein
,	O
IL-8	B-protein
,	O
and	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	I-protein
TNF	I-protein
)	I-protein
-alpha	I-protein
by	O
blocking	O
gene	O
transcription	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
,	O
we	O
now	O
show	O
that	O
,	O
in	O
monocytes	O
stimulated	O
with	O
LPS	O
or	O
TNF	B-protein
alpha	I-protein
,	O
IL-10	B-protein
inhibits	O
nuclear	O
stimulation	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF	B-protein
kappa	I-protein
B	I-protein
)	O
,	O
a	O
transcription	B-protein
factor	I-protein
involved	O
in	O
the	O
expression	O
of	O
inflammatory	B-DNA
cytokine	I-DNA
genes	I-DNA
.	O
Several	O
other	O
transcription	B-protein
factors	I-protein
including	O
NF-	O
IL-6	B-protein
,	O
AP-1	B-protein
,	O
AP-2	B-protein
,	O
GR	B-protein
,	O
CREB	B-protein
,	O
Oct-1	B-protein
,	O
and	O
Sp-1	B-protein
are	O
not	O
affected	O
by	O
IL-10	B-protein
.	O

This	O
selective	O
inhibition	O
by	O
IL-10	B-protein
of	O
NF	B-protein
kappa	I-protein
B	I-protein
activation	O
occurs	O
rapidly	O
and	O
in	O
a	O
dose-dependent	O
manner	O
and	O
correlates	O
well	O
with	O
IL-10	B-protein
's	O
cytokine	B-protein
synthesis	O
inhibitory	O
activity	O
in	O
terms	O
of	O
both	O
kinetics	O
and	O
dose	O
responsiveness	O
.	O

Furthermore	O
,	O
compounds	O
such	O
as	O
tosylphenylalanyl	O
chloromethyl	O
ketone	O
and	O
pyrrolidinedithiocarbamate	O
that	O
are	O
known	O
to	O
selectively	O
inhibit	O
NF	B-protein
kappa	I-protein
B	I-protein
activation	O
block	O
cytokine	O
gene	O
transcription	O
in	O
LPS-stimulated	B-cell_line
monocytes	I-cell_line
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
inhibition	O
of	O
NF	B-protein
kappa	I-protein
B	I-protein
activation	O
may	O
be	O
an	O
important	O
mechanism	O
for	O
IL-10	B-protein
suppression	O
of	O
cytokine	O
gene	O
transcription	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

IL-4	B-protein
,	O
another	O
cytokine	B-protein
that	O
inhibits	O
cytokine	B-RNA
mRNA	I-RNA
accumulation	O
in	O
monocytes	B-cell_type
,	O
shows	O
little	O
inhibitory	O
effect	O
on	O
LPS-induced	O
NF	B-protein
kappa	I-protein
B	I-protein
activation	O
.	O

Further	O
examination	O
reveals	O
that	O
,	O
unlike	O
IL-10	B-protein
,	O
IL-4	B-protein
enhances	O
mRNA	B-RNA
degradation	O
and	O
does	O
not	O
suppress	O
cytokine	O
gene	O
transcription	O
.	O

These	O
data	O
indicate	O
that	O
IL-10	B-protein
and	O
IL-4	B-protein
inhibit	O
cytokine	B-protein
production	O
by	O
different	O
mechanisms	O
.	O

Tak	NULL
JourNaL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

16	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
21	NULL
,	NULL
pp	NULL
.	NULL

9558-9563	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
Inhibits	NULL
Nuclear	NULL
Factor	NULL
«	NULL
B	NULL
(	NULL
NFB	NULL
)	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
IL-10	NULL
AND	NULL
IL-4	NULL
SUPPRESS	NULL
CYTOKINE	NULL
SYNTHESIS	NULL
BY	NULL
DIFFERENT	NULL
MECHANISMS*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
12	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
22	NULL
,	NULL
1995	NULL
)	NULL
Peng	NULL
Wang	NULL
,	NULL
Ping	NULL
Wu	NULL
,	NULL
Marvin	NULL
I.	NULL
Siegel	NULL
,	NULL
Robert	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
Motasim	NULL
Billah	NULL
From	NULL
the	NULL
Schering-Plough	NULL
Research	NULL
Institute	NULL
,	NULL
Kenilworth	NULL
,	NULL
New	NULL
Jersey	NULL
07038	NULL
Our	NULL
previous	NULL
studies	NULL
in	NULL
human	NULL
monocytes	NULL
have	NULL
demonstrated	NULL
that	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
inhibits	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stimulated	NULL
production	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-	NULL
«	NULL
by	NULL
blocking	NULL
gene	NULL
transcription	NULL
.	NULL

Using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
,	NULL
in	NULL
monocytes	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
TNFa	NULL
,	NULL
IL-10	NULL
inhibits	NULL
nuclear	NULL
localization	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NFxB	NULL
)	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
genes	NULL
.	NULL

Several	NULL
other	NULL
transcription	NULL
factors	NULL
including	NULL
NF-IL-6	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
GR	NULL
,	NULL
CREB	NULL
,	NULL
Oct-1	NULL
,	NULL
and	NULL
Sp-1	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
IL-10	NULL
.	NULL

This	NULL
selective	NULL
inhibition	NULL
by	NULL
IL-10	NULL
of	NULL
NFB	NULL
activation	NULL
occurs	NULL
rapidly	NULL
and	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
and	NULL
correlates	NULL
well	NULL
with	NULL
IL-10	NULL
's	NULL
cytokine	NULL
synthesis	NULL
inhibitory	NULL
activity	NULL
in	NULL
terms	NULL
of	NULL
both	NULL
kinetics	NULL
and	NULL
dose	NULL
responsiveness	NULL
.	NULL

Furthermore	NULL
,	NULL
compounds	NULL
such	NULL
as	NULL
tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
and	NULL
pyrrolidinedithiocarbamate	NULL
that	NULL
are	NULL
known	NULL
to	NULL
selectively	NULL
inhibit	NULL
NFB	NULL
activation	NULL
block	NULL
cytokine	NULL
gene	NULL
transcription	NULL
in	NULL
LPS-stimulated	NULL
monocytes	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
inhibition	NULL
of	NULL
NFB	NULL
activation	NULL
may	NULL
be	NULL
an	NULL
important	NULL
mechanism	NULL
for	NULL
IL-10	NULL
supression	NULL
of	NULL
cytokine	NULL
gene	NULL
transcription	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

IL-4	NULL
,	NULL
another	NULL
cytokine	NULL
that	NULL
inhibits	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
in	NULL
monocytes	NULL
,	NULL
shows	NULL
little	NULL
inhibitory	NULL
effect	NULL
on	NULL
LPS-induced	NULL
NFKB	NULL
activation	NULL
.	NULL

Further	NULL
examination	NULL
reveals	NULL
that	NULL
,	NULL
unlike	NULL
IL-10	NULL
,	NULL
IL-4	NULL
enhances	NULL
mRNA	NULL
degradation	NULL
and	NULL
does	NULL
not	NULL
suppress	NULL
cytokine	NULL
gene	NULL
transcription	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
IL-10	NULL
and	NULL
IL-4	NULL
inhibit	NULL
cytokine	NULL
production	NULL
by	NULL
different	NULL
mechanisms	NULL
.	NULL

Interleukin-10	NULL
(	NULL
IL-10	NULL
)	NULL
,	NULL
*	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
cytokine	NULL
synthesis	NULL
inhibitory	NULL
factor	NULL
,	NULL
inhibits	NULL
production	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cytokines	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
IL-10	NULL
suppresses	NULL
synthesis	NULL
of	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-	NULL
«	NULL
in	NULL
monocytes/macrophages	NULL
(	NULL
2-6	NULL
)	NULL
,	NULL
of	NULL
IL-1	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNFa	NULL
in	NULL
neutrophils	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
of	NULL
IL-2	NULL
,	NULL
TNF	NULL
$	NULL
,	NULL
interferon-y	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulat-ing	NULL
factor	NULL
,	NULL
and	NULL
others	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
of	NULL
cytokine	NULL
production	NULL
is	NULL
accompanied	NULL
by	NULL
reduced	NULL
accumulation	NULL
of	NULL
mRNAs	NULL
(	NULL
2-6	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
experiments	NULL
in	NULL
human	NULL
monocytes	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-10	NULL
inhibits	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccha-ride	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
TPCK	NULL
,	NULL
tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
TLCK	NULL
,	NULL
N*p-tosyl-L-ly-sine	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidinedithiocarbamate	NULL
.	NULL

induced	NULL
synthesis	NULL
of	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNFa	NULL
by	NULL
acting	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
of	NULL
IL-10	NULL
affecting	NULL
the	NULL
activities	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Gene	NULL
promoters	NULL
for	NULL
IL-1	NULL
$	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNFa	NULL
contain	NULL
multiple	NULL
cis-acting	NULL
motifs	NULL
including	NULL
those	NULL
that	NULL
bind	NULL
such	NULL
transcription	NULL
factors	NULL
as	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NFkB	NULL
)	NULL
,	NULL
NF-IL-6	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
CREB	NULL
,	NULL
GR	NULL
,	NULL
Oct-1	NULL
,	NULL
and	NULL
Sp-1	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

Motifs	NULL
for	NULL
NFB	NULL
,	NULL
NF-IL-6	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
CREB	NULL
are	NULL
common	NULL
to	NULL
all	NULL
four	NULL
cytokine	NULL
gene	NULL
promoters	NULL
,	NULL
and	NULL
recent	NULL
data	NULL
have	NULL
clearly	NULL
indicated	NULL
that	NULL
NFB	NULL
,	NULL
NF-IL-6	NULL
,	NULL
and	NULL
AP-1	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
(	NULL
8	NULL
,	NULL
12-21	NULL
)	NULL
.	NULL

NFkB	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
heterodimeric	NULL
complex	NULL
consisting	NULL
of	NULL
two	NULL
subunits	NULL
,	NULL
p65	NULL
and	NULL
p50	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
.	NULL

In	NULL
most	NULL
cells	NULL
including	NULL
monocytes	NULL
,	NULL
NFB	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
an	NULL
inactive	NULL
p65-p50-I	NULL
«	NULL
B	NULL
ternary	NULL
com-plex	NULL
.	NULL

Various	NULL
stimuli	NULL
including	NULL
LPS	NULL
induce	NULL
rapid	NULL
dissociation	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
.	NULL

The	NULL
resultant	NULL
heterodimer	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
initiates	NULL
transcription	NULL
of	NULL
appropriate	NULL
genes	NULL
in	NULL
synergy	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-IL-6	NULL
.	NULL

Like	NULL
NFkB	NULL
,	NULL
NF-IL-6	NULL
exists	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
responds	NULL
to	NULL
stimulation	NULL
by	NULL
rapidly	NULL
translocating	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
23	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
the	NULL
two	NULL
components	NULL
of	NULL
AP-1	NULL
,	NULL
are	NULL
synthesized	NULL
de	NULL
novo	NULL
during	NULL
stimulation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
data	NULL
suggest	NULL
that	NULL
IL-10	NULL
causes	NULL
selective	NULL
inhibition	NULL
of	NULL
NFB	NULL
activation	NULL
in	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
,	NULL
and	NULL
that	NULL
this	NULL
NFxB	NULL
inhibition	NULL
may	NULL
be	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
IL-10	NULL
causes	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
cytokine	NULL
production	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
demonstrate	NULL
that	NULL
IL-4	NULL
inhibits	NULL
cytokine	NULL
production	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
does	NULL
not	NULL
involve	NULL
NFkB	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Preparation	NULL
and	NULL
Incubation-Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
purified	NULL
monocytes	NULL
were	NULL
prepared	NULL
from	NULL
PBMC	NULL
by	NULL
elutriation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
elutriated	NULL
monocyte	NULL
fraction	NULL
consisted	NULL
of	NULL
>	NULL
95	NULL
%	NULL
monocytes	NULL
as	NULL
determined	NULL
by	NULL
histologic	NULL
staining	NULL
and	NULL
by	NULL
immunofluorescence	NULL
assay	NULL
for	NULL
CD14	NULL
antigen	NULL
.	NULL

Cell	NULL
incubation	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Assays	NULL
for	NULL
Cytokine	NULL
Proteins-Cytokines	NULL
released	NULL
into	NULL
cell	NULL
culture	NULL
media	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
commercially	NULL
available	NULL
specific	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
kits	NULL
(	NULL
IL-6	NULL
and	NULL
TNFa	NULL
kits	NULL
from	NULL
Bio-source	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
;	NULL
IL-18	NULL
and	NULL
IL-8	NULL
kits	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minne-apolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

The	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
are	NULL
from	NULL
representative	NULL
experiments	NULL
.	NULL

Data	NULL
points	NULL
are	NULL
the	NULL
means	NULL
of	NULL
two	NULL
determinations	NULL
,	NULL
which	NULL
were	NULL
within	NULL
10	NULL
%	NULL
,	NULL
mostly	NULL
5	NULL
%	NULL
,	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Cytokine	NULL
mRNA	NULL
levels	NULL
in	NULL
cells	NULL
after	NULL
various	NULL
treatments	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
blotting	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Cytokine	NULL
cDNA	NULL
probes	NULL
were	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
.	NULL

Nuclear	NULL
Extract	NULL
Preparation	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
specified	NULL
incubation	NULL
time	NULL
,	NULL
cells	NULL
(	NULL
15-20	NULL
x	NULL
10°	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
collected	NULL
by	NULL
centrifuging	NULL
at	NULL
350	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

After	NULL
washing	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mm	NULL
Hepes-NaOH	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
15	NULL
mM	NULL
KCl	NULL
,	NULL
2	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mx	NULL
dithiothreitol	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
9558	NULL
IL-10	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
A	NULL
B	NULL
Anti-p65	NULL
NFxB	NULL
oligo	NULL
Oct-1	NULL
oligo	NULL
None	NULL
LPS	NULL
+	NULL
IL-10	NULL
TNF	NULL
+	NULL
IL-10	NULL
TNF	NULL
o	NULL
o	NULL
C—	NULL
‘	NULL
m	NULL
9	NULL
\	NULL
m	NULL
282	NULL
3	NULL
H	NULL
©	NULL
Anti-p50	NULL
NFxB	NULL
--	NULL
>	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
LPS-	NULL
and	NULL
TNFa	NULL
«	NULL
-induced	NULL
NFB	NULL
activation	NULL
in	NULL
human	NULL
PBMC	NULL
.	NULL

A	NULL
,	NULL
the	NULL
nuclear	NULL
protein	NULL
sample	NULL
from	NULL
LPS-stimulated	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
was	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
complex	NULL
observed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
P-labeled	NULL
NFxB	NULL
oligonucleotide	NULL
probe	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
unlabeled	NULL
NFxB	NULL
and	NULL
Oct-1	NULL
oligonucleotide	NULL
probes	NULL
at	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
.	NULL

In	NULL
``	NULL
supershift	NULL
``	NULL
experiments	NULL
,	NULL
antibodies	NULL
were	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
ug	NULL
per	NULL
assay	NULL
.	NULL

B	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
80	NULL
ng/ml	NULL
LPS	NULL
or	NULL
20	NULL
ng/ml	NULL
TNFa	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
IL-10	NULL
for	NULL
1.5	NULL
h	NULL
before	NULL
the	NULL
extraction	NULL
of	NULL
nuclear	NULL
protein	NULL
for	NULL
EMSA	NULL
.	NULL

microcentrifuge	NULL
tube	NULL
then	NULL
centrifuged	NULL
at	NULL
750	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
by	NULL
aspiration	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
0.2	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
.	NULL

After	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
to	NULL
0.5	NULL
%	NULL
and	NULL
the	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
1330	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
resultant	NULL
nuclear	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
15	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mm	NULL
Hepes-NaOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

After	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
vigorous	NULL
stirring	NULL
,	NULL
the	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
16,300	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Fifteen	NULL
ul	NULL
of	NULL
the	NULL
resultant	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
75	NULL
ul	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mm	NULL
Hepes-NaOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mi	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
]	NULL
fluoride	NULL
)	NULL
to	NULL
obtain	NULL
the	NULL
final	NULL
nuclear	NULL
extract	NULL
prep-aration	NULL
.	NULL

EMSAs	NULL
for	NULL
NFxB	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
in	NULL
nuclei	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
gel	NULL
shift	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
except	NULL
that	NULL
8	NULL
%	NULL
(	NULL
instead	NULL
of	NULL
4	NULL
%	NULL
)	NULL
gels	NULL
were	NULL
used	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
contained	NULL
2	NULL
ul	NULL
of	NULL
5	NULL
x	NULL
gel	NULL
shift	NULL
binding	NULL
buffer	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
*°P-labeled	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
oligo	NULL
)	NULL
probe	NULL
of	NULL
appropriate	NULL
specificity	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
water	NULL
,	NULL
and	NULL
5	NULL
ul	NULL
of	NULL
nuclear	NULL
extract	NULL
(	NULL
1	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
.	NULL

Nuclear	NULL
Run-on	NULL
Assay-Cytokine	NULL
gene	NULL
transcription	NULL
rates	NULL
were	NULL
measured	NULL
by	NULL
nuclear	NULL
run-on	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

mRNA	NULL
Stability	NULL
Analysis-Cytokine	NULL
mRNA	NULL
stability	NULL
was	NULL
analyzed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Other	NULL
Reagents-Human	NULL
recombinant	NULL
IL-10	NULL
and	NULL
IL-4	NULL
were	NULL
from	NULL
Schering-Plough	NULL
.	NULL

Human	NULL
recombinant	NULL
TNFa	NULL
was	NULL
obtained	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
.	NULL

LPS	NULL
,	NULL
TPCK	NULL
,	NULL
TLCK	NULL
,	NULL
and	NULL
PDTC	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Consensus	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
various	NULL
transcription	NULL
factors	NULL
,	NULL
except	NULL
for	NULL
NF-IL-6	NULL
were	NULL
from	NULL
Promega	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
NF-IL-6	NULL
was	NULL
synthesized	NULL
as	NULL
reported	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
p65	NULL
and	NULL
p50	NULL
subunits	NULL
of	NULL
NFkB	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Phosphorothicate	NULL
analogs	NULL
of	NULL
NFB	NULL
oligonucleotides	NULL
,	NULL
both	NULL
sense	NULL
and	NULL
antisense	NULL
,	NULL
were	NULL
prepared	NULL
as	NULL
reported	NULL
(	NULL
13	NULL
)	NULL
.	NULL

RESULTS	NULL
IL-10	NULL
Selectively	NULL
Inhibits	NULL
NFkB	NULL
Activation-In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
IL-10	NULL
treatment	NULL
on	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
appropriately	NULL
treated	NULL
PBMC	NULL
,	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
specific	NULL
°°P-labeled	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
.	NULL

Thus	NULL
,	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-treated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
°°P-labeled	NULL
NFkB	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
a	NULL
°°P-labeled	NULL
protein-oligonucleotide	NULL
complex	NULL
was	NULL
formed	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
formation	NULL
was	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
NFKB	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
Oct-1	NULL
oligonucleotide	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
NFxB	NULL
oligonucleotide	NULL
specifically	NULL
competes	NULL
with	NULL
°°P-labeled	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
specific	NULL
antibodies	NULL
to	NULL
the	NULL
NFB	NULL
components	NULL
p50	NULL
and	NULL
p65	NULL
caused	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
P-labeled	NULL
complex	NULL
,	NULL
confirming	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
the	NULL
complex	NULL
as	NULL
NFB	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
complexed	NULL
with	NULL
cellular	NULL
NFkB	NULL
and	NULL
LPS	NULL
stimulated	NULL
NFkB	NULL
translocation	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
data	NULL
that	NULL
anti-p50	NULL
antibody	NULL
9559	NULL
caused	NULL
the	NULL
total	NULL
shift	NULL
of	NULL
the	NULL
°°P-oligonucleotide-NFxB	NULL
complex	NULL
while	NULL
anti-p65	NULL
antibody	NULL
caused	NULL
only	NULL
a	NULL
partial	NULL
shift	NULL
show	NULL
that	NULL
LPS-stimulated	NULL
nuclear	NULL
NFkB	NULL
exists	NULL
as	NULL
both	NULL
p50-p50	NULL
homodimer	NULL
and	NULL
p50-p65	NULL
heterodimer	NULL
,	NULL
with	NULL
the	NULL
homodimer	NULL
predominating	NULL
.	NULL

Incubation	NULL
of	NULL
PBMC	NULL
with	NULL
IL-10	NULL
alone	NULL
for	NULL
up	NULL
to	NULL
1.5	NULL
h	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
nuclear	NULL
NFB	NULL
.	NULL

However	NULL
,	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
5	NULL
min	NULL
before	NULL
LPS	NULL
,	NULL
NFkB	NULL
translocation	NULL
induced	NULL
by	NULL
LPS	NULL
was	NULL
completely	NULL
inhibited	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
production	NULL
of	NULL
IL-6	NULL
and	NULL
IL-8	NULL
was	NULL
also	NULL
inhibited	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
PBMC	NULL
with	NULL
a	NULL
different	NULL
stimulus	NULL
,	NULL
TNFa	NULL
,	NULL
caused	NULL
nuclear	NULL
localization	NULL
of	NULL
NFxB	NULL
,	NULL
but	NULL
to	NULL
a	NULL
smaller	NULL
degree	NULL
than	NULL
LPS	NULL
.	NULL

TNFa-induced	NULL
NFB	NULL
translocation	NULL
(	NULL
and	NULL
cytokine	NULL
synthesis	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
)	NULL
was	NULL
inhibited	NULL
by	NULL
IL-10	NULL
treatment	NULL
.	NULL

Thus	NULL
,	NULL
IL-10	NULL
inhibits	NULL
NFB	NULL
activation	NULL
in	NULL
PBMC	NULL
in	NULL
response	NULL
to	NULL
two	NULL
distinct	NULL
stimulating	NULL
agents	NULL
.	NULL

When	NULL
incubated	NULL
with	NULL
°°P-labeled	NULL
NF-IL-6	NULL
cis-acting	NULL
ele-ment	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-stimulated	NULL
PBMC	NULL
generated	NULL
a	NULL
*P	NULL
-labeled	NULL
protein-oligonucleotide	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
competed	NULL
away	NULL
with	NULL
unlabeled	NULL
NF-IL-6	NULL
oligonucleotide	NULL
but	NULL
not	NULL
with	NULL
unlabeled	NULL
Oct-1	NULL
or	NULL
NFkB	NULL
oligonucleotide	NULL
.	NULL

This	NULL
complex	NULL
formation	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
IL-10	NULL
treatment	NULL
.	NULL

LPS-stimulated	NULL
localization	NULL
of	NULL
AP-1	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
when	NULL
assessed	NULL
under	NULL
similar	NULL
conditions	NULL
,	NULL
was	NULL
also	NULL
not	NULL
inhibited	NULL
by	NULL
IL-10	NULL
.	NULL

When	NULL
incubated	NULL
with	NULL
the	NULL
°°P-labeled	NULL
cis-acting	NULL
elements	NULL
for	NULL
AP-2	NULL
,	NULL
CREB	NULL
,	NULL
GR	NULL
,	NULL
Oct-1	NULL
,	NULL
and	NULL
Sp-1	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
cells	NULL
produced	NULL
the	NULL
appropriate	NULL
°°P-labeled	NULL
protein-oligonucleotide	NULL
complexes	NULL
.	NULL

None	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
affected	NULL
by	NULL
either	NULL
LPS	NULL
or	NULL
IL-10	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IL-10	NULL
causes	NULL
selective	NULL
inhibition	NULL
of	NULL
NFkB	NULL
activation	NULL
in	NULL
LPS-stimulated	NULL
PBMC	NULL
.	NULL

Characteristics	NULL
of	NULL
IL-10	NULL
Inhibition	NULL
of	NULL
NFkB	NULL
Activation-The	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
NFkB	NULL
activation	NULL
and	NULL
cytokine	NULL
synthesis	NULL
were	NULL
dependent	NULL
on	NULL
IL-10	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Nearly	NULL
complete	NULL
inhibition	NULL
of	NULL
both	NULL
NFkB	NULL
translocation	NULL
and	NULL
cytokine	NULL
synthesis	NULL
occurred	NULL
at	NULL
1-10	NULL
ng/ml	NULL
IL-10	NULL
.	NULL

However	NULL
,	NULL
substantial	NULL
NFxB	NULL
activity	NULL
was	NULL
still	NULL
detected	NULL
at	NULL
0.1	NULL
ng/ml	NULL
IL-10	NULL
,	NULL
a	NULL
concentration	NULL
that	NULL
inhibited	NULL
TNFa	NULL
and	NULL
IL-18	NULL
synthesis	NULL
(	NULL
60	NULL
75	NULL
%	NULL
inhibition	NULL
)	NULL
more	NULL
effectively	NULL
than	NULL
it	NULL
did	NULL
IL-6	NULL
and	NULL
IL-8	NULL
synthesis	NULL
(	NULL
20-35	NULL
%	NULL
inhibition	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
differential	NULL
inhibition	NULL
pattern	NULL
suggests	NULL
that	NULL
the	NULL
threshold	NULL
levels	NULL
of	NULL
NFkB	NULL
necessary	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
vary	NULL
among	NULL
different	NULL
cytokines	NULL
and	NULL
confirms	NULL
our	NULL
previous	NULL
conclusion	NULL
that	NULL
cytokine	NULL
gene	NULL
expression	NULL
is	NULL
differentially	NULL
regulated	NULL
in	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
PBMC-derived	NULL
preparation	NULL
that	NULL
contained	NULL
>	NULL
95	NULL
%	NULL
monocytes	NULL
.	NULL

The	NULL
lymphocyte	NULL
fraction	NULL
obtained	NULL
from	NULL
the	NULL
same	NULL
PBMC	NULL
preparation	NULL
produced	NULL
neither	NULL
cytokines	NULL
nor	NULL
NFkB	NULL
translocation	NULL
.	NULL

Thus	NULL
,	NULL
cytokine	NULL
production	NULL
and	NULL
NFB	NULL
activation	NULL
and	NULL
their	NULL
inhibition	NULL
by	NULL
IL-10	NULL
in	NULL
LPS-stimulated	NULL
PBMC	NULL
were	NULL
due	NULL
primarily	NULL
to	NULL
monocytes	NULL
and	NULL
not	NULL
to	NULL
lymphocytes	NULL
,	NULL
although	NULL
the	NULL
lymphocytes	NULL
accounted	NULL
for	NULL
80	NULL
%	NULL
of	NULL
the	NULL
PBMC	NULL
population	NULL
.	NULL

In	NULL
experiments	NULL
discussed	NULL
above	NULL
where	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
NFB	NULL
activation	NULL
was	NULL
observed	NULL
,	NULL
IL-10	NULL
was	NULL
added	NULL
5	NULL
min	NULL
before	NULL
LPS	NULL
.	NULL

The	NULL
same	NULL
complete	NULL
inhibition	NULL
was	NULL
noted	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
simultaneously	NULL
with	NULL
or	NULL
2	NULL
h	NULL
before	NULL
LPS	NULL
,	NULL
suggesting	NULL
that	NULL
IL-10	NULL
acts	NULL
rapidly	NULL
to	NULL
inhibit	NULL
NFxB	NULL
activity	NULL
and	NULL
that	NULL
the	NULL
sig-nal	NULL
(	NULL
s	NULL
)	NULL
generated	NULL
by	NULL
IL-10	NULL
lasts	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similar	NULL
rapid	NULL
inhibitions	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
with	NULL
both	NULL
cytokine	NULL
protein	NULL
synthesis	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
6	NULL
)	NULL
,	NULL
demonstrating	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
NFkB	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NFxB	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
preceded	NULL
cytokine	NULL
mRNA	NULL
accumula-tion	NULL
,	NULL
and	NULL
nuclear	NULL
NFB	NULL
activity	NULL
reached	NULL
a	NULL
maximum	NULL
within	NULL
30	NULL
min	NULL
of	NULL
LPS	NULL
addition	NULL
and	NULL
remained	NULL
virtually	NULL
unchanged	NULL
over	NULL
the	NULL
next	NULL
2.5	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
IL-10	NULL
was	NULL
added	NULL
0.5	NULL
h	NULL
or	NULL
9560	NULL
B	NULL
|00	NULL
``	NULL
———_T	NULL
80	NULL
A	NULL
E225	NULL
?	NULL

so	NULL
RE	NULL
&	NULL
40	NULL
IL-1B	NULL
t	NULL
=E°=	NULL
20	NULL
§	NULL
sis	NULL
°	NULL
to	NULL
<	NULL
v	NULL
n/	NULL
=	NULL
-	NULL
000	NULL
so	NULL
©	NULL
NTT	NULL
-	NULL
il	NULL
pd	NULL
+d	NULL
60	NULL
v_	NULL
AER	NULL
a	NULL
aol	NULL
IL-6	NULL
o	NULL
+++	NULL
g	NULL
©	NULL
L	NULL
:	NULL
``	NULL
C	NULL
z	NULL
H	NULL
add	NULL
3	NULL
s	NULL
*	NULL
wil	NULL
3	NULL
so	NULL
NFxB	NULL
--	NULL
>	NULL
%	NULL
is	NULL
a	NULL
-	NULL
E	NULL
so	NULL
!	NULL

30	NULL
IL-8	NULL
20	NULL
0	NULL
y	NULL
80	NULL
it	NULL
TN	NULL
40	NULL
F	NULL
20	NULL
0	NULL
0.1	NULL
1	NULL
10	NULL
IL-10	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Fic	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
IL-10	NULL
concentrations	NULL
on	NULL
LPS-induced	NULL
NFB	NULL
activation	NULL
and	NULL
cytokine	NULL
release	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

A	NULL
,	NULL
various	NULL
concentrations	NULL
of	NULL
IL-10	NULL
were	NULL
added	NULL
5	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
80	NULL
ng/ml	NULL
LPS	NULL
.	NULL

After	NULL
1.5	NULL
h	NULL
,	NULL
nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

B	NULL
,	NULL
an	NULL
aliquot	NULL
of	NULL
cell	NULL
suspension	NULL
from	NULL
each	NULL
of	NULL
the	NULL
culture	NULL
samples	NULL
used	NULL
for	NULL
EMSA	NULL
was	NULL
further	NULL
incubated	NULL
for	NULL
a	NULL
total	NULL
period	NULL
of	NULL
4	NULL
h.	NULL
Cytokines	NULL
released	NULL
to	NULL
the	NULL
supernatants	NULL
were	NULL
measured	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
IL-18	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNFa	NULL
produced	NULL
by	NULL
LPS	NULL
stimulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-10	NULL
were	NULL
2.4	NULL
,	NULL
17.0	NULL
,	NULL
120.6	NULL
,	NULL
and	NULL
3.1	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

=	NULL
i	NULL
zs	NULL
$	NULL
2	NULL
2	NULL
0	NULL
§	NULL
2	NULL
a	NULL
G	NULL
Bo	NULL
g	NULL
®	NULL
a	NULL
2	NULL
``	NULL
?	NULL

g	NULL
a	NULL
20	NULL
#	NULL
sSsSz	NULL
o	NULL
0	NULL
0	NULL
0	NULL
indarar	NULL
)	NULL
pd	NULL
sl	NULL
t	NULL
sd	NULL
m	NULL
E	NULL
a	NULL
m	NULL
$	NULL
+	NULL
+	NULL
+	NULL
+	NULL
&	NULL
oamn	NULL
nuo	NULL
O	NULL
A	NULL
.	NULL

A	NULL
,	NULL
A.	NULL
,	NULL
C	NULL
Z	NULL
m	NULL
sd	NULL
lsd	NULL
+3	NULL
aly	NULL
w	NULL
ie	NULL
NFxB	NULL
--	NULL
>	NULL
*	NULL
#	NULL
&	NULL
.	NULL

%	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
addition	NULL
time	NULL
on	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
NFB	NULL
activation	NULL
in	NULL
human	NULL
PBMC	NULL
.	NULL

IL-10	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
2	NULL
h	NULL
prior	NULL
to	NULL
,	NULL
0	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
1	NULL
h	NULL
after	NULL
LPS	NULL
(	NULL
80	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
LPS	NULL
for	NULL
a	NULL
total	NULL
period	NULL
of	NULL
1.5	NULL
h.	NULL
For	NULL
all	NULL
other	NULL
details	NULL
,	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

1	NULL
h	NULL
after	NULL
LPS	NULL
during	NULL
an	NULL
LPS	NULL
stimulation	NULL
period	NULL
of	NULL
1.5	NULL
h	NULL
,	NULL
substantial	NULL
inhibition	NULL
of	NULL
NFkB	NULL
activity	NULL
was	NULL
still	NULL
observed	NULL
and	NULL
was	NULL
more	NULL
pronounced	NULL
at	NULL
0.5	NULL
h	NULL
than	NULL
at	NULL
1	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
supports	NULL
the	NULL
view	NULL
that	NULL
nuclear	NULL
NFkB	NULL
undergoes	NULL
rapid	NULL
turnover	NULL
during	NULL
LPS	NULL
stimulation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NFkB	NULL
May	NULL
Be	NULL
Sufficient	NULL
for	NULL
Suppressed	NULL
Synthesis	NULL
of	NULL
Inflammatory	NULL
Cytokines-To	NULL
determine	NULL
whether	NULL
inhibition	NULL
of	NULL
NFkB	NULL
activation	NULL
is	NULL
sufficient	NULL
for	NULL
suppression	NULL
of	NULL
cytokine	NULL
production	NULL
,	NULL
two	NULL
non-peptide	NULL
inhibitors	NULL
of	NULL
NFxB	NULL
activation	NULL
were	NULL
investigated	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
cytokine	NULL
mRNA	NULL
synthesis	NULL
.	NULL

TPCK	NULL
,	NULL
a	NULL
chymotrypsin-like	NULL
serine	NULL
protease	NULL
inhibi-tor	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
NFxB	NULL
activation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
our	NULL
system	NULL
,	NULL
TPCK	NULL
inhibited	NULL
LPS-induced	NULL
NFxB	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
accumulation	NULL
of	NULL
IL-1	NULL
$	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNFa	NULL
mRNAs	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
and	NULL
,	NULL
at	NULL
20	NULL
pun	NULL
,	NULL
both	NULL
responses	NULL
were	NULL
IL-10	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
completely	NULL
inhibited	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

TLCK	NULL
,	NULL
an	NULL
analog	NULL
of	NULL
TPCK	NULL
with	NULL
inhibitory	NULL
activity	NULL
against	NULL
trypsin-like	NULL
serine	NULL
proteases	NULL
(	NULL
28	NULL
)	NULL
,	NULL
inhibited	NULL
neither	NULL
NFkB	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
nor	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
in	NULL
LPS-stimulated	NULL
PBMC	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
,	NULL
it	NULL
has	NULL
been	NULL
published	NULL
that	NULL
the	NULL
antioxidant	NULL
,	NULL
PDTC	NULL
,	NULL
inhibits	NULL
NFxB	NULL
activation	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
and	NULL
TNFa	NULL
synthesis	NULL
(	NULL
30	NULL
)	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
PDTC	NULL
by	NULL
itself	NULL
caused	NULL
slight	NULL
accumulation	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
,	NULL
but	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
accumulation	NULL
of	NULL
various	NULL
cytokine	NULL
mRNAs	NULL
was	NULL
still	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
relative	NULL
specificity	NULL
with	NULL
which	NULL
these	NULL
two	NULL
compounds	NULL
(	NULL
TPCK	NULL
in	NULL
particular	NULL
)	NULL
inhibit	NULL
NFkB	NULL
among	NULL
various	NULL
transcription	NULL
factors	NULL
tested	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
our	NULL
present	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
NFkB	NULL
inhibition	NULL
being	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
.	NULL

An	NULL
antisense	NULL
oligonucleotide	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NFkB	NULL
inhibits	NULL
IL-8	NULL
production	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
(	NULL
13	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
antisense	NULL
oligonucleotide	NULL
on	NULL
the	NULL
production	NULL
of	NULL
IL-1	NULL
3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNFa	NULL
by	NULL
LPS-stimulated	NULL
PBMC	NULL
.	NULL

Preincubation	NULL
of	NULL
cells	NULL
with	NULL
the	NULL
antisense	NULL
oligonucleotide	NULL
for	NULL
4-8	NULL
h	NULL
resulted	NULL
in	NULL
an	NULL
inhibition	NULL
of	NULL
cytokine	NULL
synthesis	NULL
by	NULL
50	NULL
%	NULL
to	NULL
70	NULL
%	NULL
,	NULL
probably	NULL
due	NULL
to	NULL
insufficient	NULL
uptake	NULL
of	NULL
the	NULL
oligonucleotide	NULL
.	NULL

Upon	NULL
longer	NULL
preincubations	NULL
,	NULL
the	NULL
oligonucleotide	NULL
itself	NULL
induced	NULL
cytokine	NULL
synthesis	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
inhibition	NULL
of	NULL
NFB	NULL
activation	NULL
may	NULL
be	NULL
sufficient	NULL
for	NULL
suppression	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
various	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

IL-4	NULL
Does	NULL
Not	NULL
Inhibit	NULL
NFB	NULL
Activation-The	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
LPS-induced	NULL
NFxB	NULL
activation	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
IL-4	NULL
,	NULL
because	NULL
IL-4	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
cytokine	NULL
synthesis	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
present	NULL
experimental	NULL
conditions	NULL
,	NULL
maximal	NULL
IL-4	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
synthesis	NULL
of	NULL
the	NULL
cytokines	NULL
was	NULL
80	NULL
%	NULL
(	NULL
IL-1	NULL
$	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
)	NULL
or	NULL
70	NULL
%	NULL
(	NULL
TNFa	NULL
)	NULL
.	NULL

The	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
were	NULL
also	NULL
similarly	NULL
inhibited	NULL
.	NULL

However	NULL
,	NULL
at	NULL
10	NULL
ng/ml	NULL
,	NULL
that	NULL
was	NULL
optimal	NULL
for	NULL
its	NULL
inhibitory	NULL
effects	NULL
on	NULL
cytokine	NULL
synthesis	NULL
,	NULL
IL-4	NULL
caused	NULL
no	NULL
significant	NULL
suppression	NULL
of	NULL
the	NULL
NFB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
synthesis	NULL
by	NULL
IL-4	NULL
does	NULL
not	NULL
involve	NULL
NFB	NULL
.	NULL

Nuclear	NULL
run-on	NULL
experiments	NULL
revealed	NULL
no	NULL
inhibition	NULL
by	NULL
IL-4	NULL
of	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
while	NULL
mRNA	NULL
stability	NULL
analysis	NULL
showed	NULL
that	NULL
IL-4	NULL
treatment	NULL
did	NULL
enhance	NULL
the	NULL
degradation	NULL
of	NULL
various	NULL
cytokine	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
IL-4	NULL
not	NULL
inhibiting	NULL
NFxB	NULL
activation	NULL
and	NULL
indicate	NULL
that	NULL
IL-4	NULL
and	NULL
IL-10	NULL
inhibit	NULL
cytokine	NULL
synthesis	NULL
in	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
through	NULL
distinct	NULL
mechanisms	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
in	NULL
human	NULL
monocytes	NULL
that	NULL
IL-10	NULL
inhibits	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
by	NULL
acting	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
possible	NULL
mechanism	NULL
of	NULL
IL-10	NULL
action	NULL
through	NULL
transcription	NULL
factors	NULL
.	NULL

Several	NULL
approaches	NULL
using	NULL
mutation	NULL
or	NULL
deletion	NULL
of	NULL
kB	NULL
sequence	NULL
,	NULL
overexpression	NULL
of	NULL
NFkB	NULL
proteins	NULL
,	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
NFkB	NULL
,	NULL
and	NULL
the	NULL
NFkB	NULL
DNA	NULL
binding	NULL
sequence	NULL
have	NULL
provided	NULL
data	NULL
to	NULL
strongly	NULL
implicate	NULL
NFkB	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
monocytes	NULL
(	NULL
8	NULL
,	NULL
12-14	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Additional	NULL
studies	NULL
have	NULL
further	NULL
suggested	NULL
that	NULL
NFxB	NULL
acts	NULL
synergistically	NULL
with	NULL
NF-IL-6	NULL
and	NULL
AP-1	NULL
to	NULL
effect	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-10	NULL
inhibits	NULL
NFxB	NULL
activation	NULL
in	NULL
stimulated	NULL
human	NULL
monocytes	NULL
without	NULL
affecting	NULL
AP-1	NULL
,	NULL
NF-IL-6	NULL
,	NULL
or	NULL
other	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
transcription	NULL
.	NULL

This	NULL
selective	NULL
inhibition	NULL
of	NULL
NFkB	NULL
activation	NULL
occurs	NULL
rapidly	NULL
and	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
and	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
transcription	NULL
in	NULL
terms	NULL
of	NULL
both	NULL
time	NULL
course	NULL
and	NULL
dose-response	NULL
,	NULL
indicating	NULL
that	NULL
IL-10	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
me	NULL
IL-10	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
TPCK	NULL
,	NULL
TLCK	NULL
,	NULL
and	NULL
PDTC	NULL
on	NULL
LPS-induced	NULL
NFxB	NULL
activation	NULL
and	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
in	NULL
human	NULL
PBMC	NULL
.	NULL

A	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPCK	NULL
at	NULL
the	NULL
specified	NULL
con-	NULL
A	NULL
centrations	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
80	NULL
ng/ml	NULL
LPS	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

B	NULL
,	NULL
various	NULL
inhibitors	NULL
as	NULL
indicated	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
suspension	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
2.5	NULL
h	NULL
before	NULL
extracting	NULL
total	NULL
RNA	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

For	NULL
details	NULL
,	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

TPCK	NULL
(	NULL
20	NULL
uM	NULL
)	NULL
``	NULL
~	NULL
f	NULL
‘	NULL
None	NULL
NFxB	NULL
--	NULL
>	NULL
o	NULL
AL	NULL
-	NULL
o	NULL
{	NULL
o-	NULL
A.	NULL
o	NULL
t	NULL
/T	NULL
a	NULL
L	NULL
0	NULL
gm	NULL
.	NULL

'—	NULL
‘	NULL
“	NULL
r	NULL
<	NULL
f	NULL
s	NULL
r	NULL
7	NULL
z	NULL
in	NULL
f	NULL
fo	NULL
NFxB	NULL
--	NULL
>	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
LPS-induced	NULL
NFxB	NULL
activation	NULL
in	NULL
human	NULL
PBMC	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
80	NULL
ng/ml	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
each	NULL
of	NULL
IL-10	NULL
or	NULL
IL-4	NULL
for	NULL
1.5	NULL
h.	NULL
Nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

q	NULL
None	NULL
IL-4	NULL
LPS	NULL
LPS	NULL
IL-4	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
LPS-stimulated	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
PBMC	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
80	NULL
ng/ml	NULL
LPS	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
,	NULL
as	NULL
specified	NULL
,	NULL
for	NULL
2	NULL
h.	NULL
Nuclei	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

diated	NULL
by	NULL
the	NULL
blockade	NULL
of	NULL
NFxB	NULL
activation	NULL
.	NULL

Although	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TPCK	NULL
and	NULL
PDTC	NULL
may	NULL
elicit	NULL
broader	NULL
effects	NULL
than	NULL
inhibition	NULL
of	NULL
NFB	NULL
only	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
these	NULL
compounds	NULL
do	NULL
not	NULL
affect	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
Oct-1	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
Sp-1	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
and	NULL
that	NULL
a	NULL
structural	NULL
analog	NULL
of	NULL
TPCK	NULL
is	NULL
without	NULL
effect	NULL
on	NULL
NFB	NULL
activation	NULL
or	NULL
on	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
selectivity	NULL
with	NULL
regard	NULL
to	NULL
NFB	NULL
inhibition	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
by	NULL
TPCK	NULL
and	NULL
PDTC	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
observations	NULL
that	NULL
antisense	NULL
oligonucleotides	NULL
and	NULL
the	NULL
NFkB	NULL
binding	NULL
sequence	NULL
inhibit	NULL
cytokine	NULL
mRNA	NULL
synthesis	NULL
would	NULL
indicate	NULL
that	NULL
the	NULL
blockade	NULL
of	NULL
NFkB	NULL
activation	NULL
might	NULL
indeed	NULL
be	NULL
9561	NULL
Le	NULL
a	NULL
a	NULL
3	NULL
$	NULL
%	NULL
$	NULL
4	NULL
``	NULL
``	NULL
s	NULL
s	NULL
Lws	NULL
ou	NULL
Gy	NULL
G	NULL
200	NULL
a	NULL
o	NULL
¥M++¥+UU++	NULL
kow	NULL
ono	NULL
&	NULL
&	NULL
Z	NULL
2	NULL
BF	NULL
d	NULL
_id	NULL
_	NULL
mm	NULL
l	NULL
2d	NULL
a	NULL
oa	NULL
a	NULL
6	NULL
11	NULL
;	NULL
a	NULL
a	NULL
%	NULL
3	NULL
.	NULL

3	NULL
3	NULL
w	NULL
2	NULL
8	NULL
8	NULL
5g	NULL
8	NULL
M	NULL
2	NULL
§	NULL
%	NULL
©	NULL
0	NULL
@	NULL
-	NULL
-	NULL
@	NULL
s	NULL
[	NULL
-s	NULL
2	NULL
2	NULL
2	NULL
E	NULL
&	NULL
&	NULL
+o	NULL
+	NULL
+	NULL
9	NULL
FP	NULL
tn	NULL
*-	NULL
@	NULL
_-	NULL
_	NULL
||	NULL
;	NULL
_	NULL
;	NULL
g	NULL
Bo	NULL
B	NULL
-	NULL
A.	NULL
wl	NULL
-	NULL
pud	NULL
orang	NULL
mm	NULL
A	NULL
-Q-	NULL
¢-~-0	NULL
@	NULL
s	NULL
TNF	NULL
w	NULL
whe	NULL
@	NULL
«	NULL
wwe	NULL
eee	NULL
=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
11	NULL
12	NULL
sufficient	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
transcription	NULL
,	NULL
thus	NULL
supporting	NULL
the	NULL
view	NULL
that	NULL
NFkB	NULL
is	NULL
a	NULL
potentially	NULL
important	NULL
target	NULL
for	NULL
IL-10	NULL
's	NULL
inhibitory	NULL
action	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Our	NULL
data	NULL
,	NULL
however	NULL
,	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
IL-10	NULL
exerts	NULL
its	NULL
inhibitory	NULL
action	NULL
on	NULL
cytokine	NULL
gene	NULL
transcription	NULL
through	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

While	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
NF-IL-6	NULL
,	NULL
Oct-1	NULL
,	NULL
Sp-1	NULL
,	NULL
and	NULL
CREB	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
IL-10	NULL
,	NULL
IL-10	NULL
does	NULL
cause	NULL
a	NULL
rapid	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
p91	NULL
,	NULL
a	NULL
component	NULL
of	NULL
the	NULL
protein	NULL
complex	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
interferon-y	NULL
response	NULL
region	NULL
(	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
complex	NULL
in	NULL
cytokine	NULL
gene	NULL
transcription	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
from	NULL
mice	NULL
lacking	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NFkB	NULL
,	NULL
TNFa	NULL
and	NULL
IL-1a	NULL
«	NULL
release	NULL
are	NULL
normal	NULL
(	NULL
34	NULL
)	NULL
,	NULL
suggesting	NULL
NFxB-independent	NULL
regulation	NULL
of	NULL
the	NULL
cytokine	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
the	NULL
in	NULL
vivo	NULL
role	NULL
of	NULL
p50	NULL
in	NULL
cytokine	NULL
gene	NULL
regulation	NULL
can	NULL
be	NULL
compensated	NULL
for	NULL
by	NULL
other	NULL
members	NULL
of	NULL
the	NULL
NFkB	NULL
family	NULL
(	NULL
e.g	NULL
.	NULL

p65	NULL
)	NULL
.	NULL

A	NULL
definitive	NULL
assessment	NULL
of	NULL
the	NULL
role	NULL
of	NULL
NFxB	NULL
in	NULL
gene	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
must	NULL
await	NULL
evaluation	NULL
of	NULL
animals	NULL
with	NULL
targeted	NULL
disruption	NULL
of	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
IL-4	NULL
inhibits	NULL
cytokine	NULL
synthesis	NULL
and	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
by	NULL
enhancing	NULL
cytokine	NULL
mRNA	NULL
degradation	NULL
suggests	NULL
the	NULL
existence	NULL
in	NULL
human	NULL
monocytes	NULL
of	NULL
a	NULL
transcription	NULL
factor-independent	NULL
mechanism	NULL
.	NULL

This	NULL
mechanism	NULL
is	NULL
not	NULL
stimulated	NULL
by	NULL
IL-10	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
our	NULL
observation	NULL
that	NULL
IL-10	NULL
has	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
cytokine	NULL
mRNA	NULL
stability	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
murine	NULL
peritoneal	NULL
(	NULL
35	NULL
)	NULL
and	NULL
porcine	NULL
alveolar	NULL
(	NULL
36	NULL
)	NULL
macrophages	NULL
,	NULL
IL-4	NULL
inhibits	NULL
cytokine	NULL
gene	NULL
transcription	NULL
with	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
mRNA	NULL
stability	NULL
,	NULL
whereas	NULL
,	NULL
in	NULL
these	NULL
same	NULL
systems	NULL
,	NULL
IL-10	NULL
appears	NULL
to	NULL
act	NULL
by	NULL
enhancing	NULL
mRNA	NULL
degradation	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
IL-4	NULL
and	NULL
IL-10	NULL
generate	NULL
distinct	NULL
signals	NULL
affecting	NULL
distinct	NULL
steps	NULL
in	NULL
cytokine	NULL
mRNA	NULL
metabolism	NULL
and	NULL
that	NULL
the	NULL
mechanisms	NULL
employed	NULL
by	NULL
these	NULL
two	NULL
inhibitory	NULL
cytokines	NULL
vary	NULL
depending	NULL
on	NULL
the	NULL
animal	NULL
species	NULL
.	NULL

IL-10	NULL
action	NULL
on	NULL
NFxB	NULL
most	NULL
likely	NULL
involves	NULL
the	NULL
blockade	NULL
of	NULL
a	NULL
reaction	NULL
required	NULL
for	NULL
release	NULL
of	NULL
IxB	NULL
from	NULL
the	NULL
NFB	NULL
complex	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Experiments	NULL
using	NULL
cell-free	NULL
preparations	NULL
have	NULL
suggested	NULL
that	NULL
protein	NULL
kinases	NULL
such	NULL
as	NULL
protein	NULL
kinase	NULL
C	NULL
phospho-rylate	NULL
IxB	NULL
causing	NULL
its	NULL
release	NULL
and	NULL
ensuing	NULL
activation	NULL
of	NULL
NFxB	NULL
9562	NULL
IL-10	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
120	NULL
Tip	NULL
IL-1B	NULL
bese	NULL
«	NULL
-	NULL
&	NULL
40	NULL
{	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
degradation	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
in	NULL
LPS-	NULL
0	NULL
IL-6	NULL
stimulated	NULL
human	NULL
PBMC	NULL
.	NULL

A	NULL
,	NULL
cells	NULL
were	NULL
.	NULL

-	NULL
&	NULL
«	NULL
»	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
80	NULL
ng/ml	NULL
LPS	NULL
IL-6	NULL
se	NULL
e	NULL
e	NULL
gg	NULL
go-	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
20	NULL
ng/ml	NULL
IL-4	NULL
and	NULL
80	NULL
ng/ml	NULL
LPS	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
for	NULL
2	NULL
h	NULL
before	NULL
actinomycin	NULL
D	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
5	NULL
g	NULL
4	NULL
``	NULL
ug/ml	NULL
to	NULL
stop	NULL
RNA	NULL
synthesis	NULL
.	NULL

At	NULL
various	NULL
times	NULL
after	NULL
actinomycin	NULL
D	NULL
addition	NULL
(	NULL
lanes	NULL
t	NULL
%	NULL
1	NULL
and	NULL
5	NULL
,	NULL
0	NULL
h	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
1	NULL
h	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
IL-8	NULL
w	NULL
u	NULL
“	NULL
,	NULL
LL-8	NULL
7	NULL
,	NULL
2	NULL
h	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
3	NULL
h	NULL
)	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
é	NULL
€	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
4	NULL
so	NULL
{	NULL
analysis	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

B	NULL
,	NULL
the	NULL
autoradiographic	NULL
signals	NULL
were	NULL
quantified	NULL
by	NULL
using	NULL
laser	NULL
a	NULL
f	NULL
404	NULL
densitometry	NULL
.	NULL

The	NULL
plotted	NULL
values	NULL
repre-	NULL
TNF	NULL
w	NULL
#	NULL
&	NULL
a	NULL
a	NULL
sent	NULL
the	NULL
percentage	NULL
of	NULL
mRNA	NULL
that	NULL
was	NULL
F	NULL
present	NULL
at	NULL
the	NULL
time	NULL
of	NULL
actinomycin	NULL
D	NULL
ad-	NULL
TNF	NULL
dition	NULL
.	NULL

O	NULL
,	NULL
LPS	NULL
only	NULL
;	NULL
®	NULL
,	NULL
LPS	NULL
plus	NULL
IL-4	NULL
.	NULL

8	NULL
gig	NULL
``	NULL
2	NULL
80-k	NULL
#	NULL
>	NULL
=	NULL
.	NULL

B-actin	NULL
w	NULL
»	NULL
us	NULL
as	NULL
wo	NULL
_	NULL
us	NULL
un	NULL
«	NULL
»	NULL
uh	NULL
s	NULL
0	NULL
t	NULL
t	NULL
t	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
(	NULL
1	NULL
2	NULL
3	NULL
a	NULL
Time	NULL
(	NULL
Hr	NULL
)	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Although	NULL
phorbol	NULL
myristate	NULL
acetate-induced	NULL
activation	NULL
of	NULL
REFERENCES	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
involve	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
other	NULL
NFB	NULL
acti-	NULL
1	NULL
.	NULL

Moore	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
O'Garra	NULL
,	NULL
A.	NULL
,	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
F	NULL
F	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
165-190	NULL
Vatlng	NULL
agents	NULL
such	NULL
as	NULL
TNFa	NULL
and	NULL
IL-1	NULL
appear	NULL
not	NULL
to	NULL
require	NULL
2.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Abrams	NULL
,	NULL
J.	NULL
,	NULL
Bennett	NULL
,	NULL
B.	NULL
,	NULL
Figdor	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
de	NULL
Vries	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
has	NULL
demonstrated	NULL
that	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1209-1220	NULL
several	NULL
NFB	NULL
activators	NULL
including	NULL
LPS	NULL
,	NULL
IL-1	NULL
,	NULL
TNFa	NULL
and	NULL
phor-	NULL
_	NULL
3	NULL
:	NULL
Ficrentino	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Zlotnils	NULL
A.	NULL
Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Howard	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
O'Garra	NULL
,	NULL
A.	NULL
M	NULL
.	NULL

&	NULL
.	NULL

98	NULL
.	NULL

Imm	NULL
7	NULL
s	NULL
bol	NULL
ester	NULL
activate	NULL
a	NULL
chymotrypsin-like	NULL
serine	NULL
protease	NULL
that	NULL
rap-	NULL
__	NULL
4	NULL
.	NULL

Bogdan	NULL
,	NULL
C.	NULL
,	NULL
Paik	NULL
,	NULL
J.	NULL
,	NULL
Vodovotz	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
idly	NULL
degrades	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
23301-23308	NULL
f	NULL
50	NULL
f	NULL
the	NULL
NFkB	NULL
1	NULL
ie	NULL
derived	NULL
I	NULL
he	NULL
i	NULL
5	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Anthes	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Siegel	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Egan	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Billah	NULL
,	NULL
M.	NULL
M.	NULL
p	NULL
component	NULL
of	NULL
the	NULL
kB	NULL
complex	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
inac-	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2678-2683	NULL
tive	NULL
cytosolic	NULL
precursor	NULL
protein	NULL
p105	NULL
through	NULL
a	NULL
proteolytic	NULL
_	NULL
6	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Siegel	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Egan	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Billah	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
811-816	NULL
cleavage	NULL
(	NULL
27	NULL
)	NULL
catalyzed	NULL
presumably	NULL
by	NULL
an	NULL
ATP-dependent	NULL
Set-	NULL
7	NULL
;	NULL
pylronting	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Zlotnik	NULL
,	NULL
A.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Howard	NULL
,	NULL
M.	NULL
,	NULL
Moore	NULL
,	NULL
ine	NULL
protease	NULL
activity	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
this	NULL
proteolytic	NULL
cleavage	NULL
occurs	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
3444-3451	NULL
within	NULL
15	NULL
min	NULL
after	NULL
LPS	NULL
addition	NULL
(	NULL
27	NULL
)	NULL
.	NULL

That	NULL
this	NULL
latter	NULL
process	NULL
8	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
Saito	NULL
,	NULL
K.	NULL
,	NULL
Bonagura	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Galgon	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Webb	NULL
,	NULL
:	NULL
.	NULL

-	NULL
.	NULL

A.	NULL
C.	NULL
,	NULL
and	NULL
Auron	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
1332-1344	NULL
might	NULL
also	NULL
be	NULL
a	NULL
target	NULL
for	NULL
IL-10	NULL
action	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
fact	NULL
9	NULL
.	NULL

Droogmans	NULL
,	NULL
L.	NULL
,	NULL
Cludts	NULL
,	NULL
I.	NULL
,	NULL
Cleuter	NULL
,	NULL
Y.	NULL
,	NULL
Kettmann	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Burny	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
that	NULL
the	NULL
p50	NULL
homodimer	NULL
predominates	NULL
in	NULL
the	NULL
nucleus	NULL
from	NULL
$	NULL
DNA	NULL
Sequcgllfc	NULL
8	NULL
,	NULL
11315—113M	NULL
fm	NULL
&	NULL
#	NULL
3	NULL
paras	NULL
F	NULL
R	NULL
+	NULL
mod	NULL
+	NULL
10	NULL
.	NULL

Mukaida	NULL
,	NULL
N.	NULL
,	NULL
Shiroo	NULL
,	NULL
M.	NULL
,	NULL
an	NULL
atsushima	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

143	NULL
,	NULL
.LPS-st1mu1ated	NULL
monocytes	NULL
and	NULL
that	NULL
this	NULL
translocation	NULL
is	NULL
inhib-	NULL
1371	NULL
ited	NULL
by	NULL
IL-10	NULL
.	NULL

11	NULL
.	NULL

Takashiba	NULL
,	NULL
S.	NULL
,	NULL
Shapira	NULL
,	NULL
L.	NULL
,	NULL
Amar	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Van	NULL
Dyke	NULL
,	NULL
T.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

t	NULL
s	NULL
h	NULL
131	NULL
,	NULL
307-308	NULL
The	NULL
protease	NULL
activities	NULL
involved	NULL
in	NULL
the	NULL
processing	NULL
of	NULL
p105	NULL
ANd	NULL
_	NULL
19	NULL
1	NULL
;	NULL
y	NULL
7	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
IkB	NULL
are	NULL
likely	NULL
regulated	NULL
by	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
Such	NULL
_	NULL
13	NULL
.	NULL

Kunsch	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6137-6146	NULL
as	NULL
hydroxyl	NULL
radical	NULL
,	NULL
based	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
various	NULL
14	NULL
.	NULL

Drouet	NULL
,	NULL
C.	NULL
,	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
§	NULL
.	NULL

.	NULL

.	NULL

1694-1700	NULL
NFxB	NULL
inducers	NULL
produce	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
that	NULL
_	NULL
15	NULL
,	NULL
zhang	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Rom	NULL
,	NULL
W.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3831-3837	NULL
antioxidants	NULL
and	NULL
radical	NULL
scavengers	NULL
inhibit	NULL
NFkB	NULL
activation	NULL
_	NULL
16	NULL
.	NULL

Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Shimamoto	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
:	NULL
s	NULL
A	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2757-2764	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Because	NULL
IL-10	NULL
blocks	NULL
NFkB	NULL
activation	NULL
in	NULL
response	NULL
t0	NULL
1	NULL
;	NULL
yugaida	NULL
,	NULL
N.	NULL
,	NULL
Mahe	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Matsushima	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
21128-distinct	NULL
NFkB	NULL
inducers	NULL
such	NULL
as	NULL
LPS	NULL
and	NULL
TNFa	NULL
,	NULL
IL-10-induced	NULL
21133	NULL
signals	NULL
seem	NULL
to	NULL
interfere	NULL
with	NULL
the	NULL
activi	NULL
n	NULL
mes-	NULL
18	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Hashimoto	NULL
,	NULL
S.	NULL
,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Isshiki	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Sn	NULL
fere	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
common	NULL
mes	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
460-466	NULL
senger	NULL
prOduced	NULL
by	NULL
different	NULL
Slgnahng	NULL
Pathways	NULL
,	NULL
and	NULL
this	NULL
mes-	NULL
19	NULL
.	NULL

Yasumoto	NULL
,	NULL
K.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
,	NULL
Mukaida	NULL
,	NULL
N.	NULL
,	NULL
Murakami	NULL
,	NULL
S.	NULL
,	NULL
Mai	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
senger	NULL
might	NULL
well	NULL
be	NULL
a	NULL
reactive	NULL
oxygen	NULL
intermediate	NULL
.	NULL

There-	NULL
Matsushima	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
22506-22511	NULL
fo	NULL
it	NULL
will	NULL
be	NULL
int	NULL
€	NULL
to	NULL
det	NULL
;	NULL
hether	NULL
IL-10	NULL
inhibi	NULL
20	NULL
.	NULL

Serkkola	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Hurme	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

213	NULL
,	NULL
243-249	NULL
ore	NULL
,	NULL
1	NULL
V511	NULL
e	NULL
interesting	NULL
to	NULL
ae	NULL
.ermme	NULL
whe	NULL
er	NULL
?	NULL

&	NULL
inhibits	NULL
21	NULL
.	NULL

Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Golub	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Economou	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
metabolism	NULL
of	NULL
precursor	NULL
proteins	NULL
and	NULL
formation	NULL
of	NULL
reactive	NULL
22102-22107	NULL
A	NULL
f	NULL
22	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
oxygen	NULL
intermediates	NULL
.	NULL

,	NULL
23	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Cortese	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
8202-8206	NULL
In	NULL
conclusion	NULL
,	NULL
the	NULL
present	NULL
study	NULL
shows	NULL
that	NULL
the	NULL
cytokine	NULL
_	NULL
24	NULL
.	NULL

Dokter	NULL
,	NULL
W.	NULL
H.	NULL
A.	NULL
,	NULL
Esselink	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Halie	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Vellenga	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
synthesis	NULL
inhibitory	NULL
activity	NULL
of	NULL
IL-10	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
inhi-	NULL
81	NULL
,	NULL
337-343	NULL
by	NULL
.	NULL

f	NULL
y	NULL
8	NULL
.y	NULL
a	NULL
a	NULL
Y	NULL
25	NULL
.	NULL

Wahl	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Katona	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Wilder	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Winter	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Haroui	NULL
,	NULL
B.	NULL
,	NULL
Scher	NULL
,	NULL
I.	NULL
,	NULL
ition	NULL
of	NULL
NFkB	NULL
activation	NULL
in	NULL
activated	NULL
human	NULL
monocytes	NULL
,	NULL
and	NULL
and	NULL
Wahl	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
Immunol	NULL
.	NULL

85	NULL
,	NULL
373-383	NULL
that	NULL
the	NULL
major	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
inhibits	NULL
cytokine	NULL
26	NULL
.	NULL

513255701	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Hsu	NULL
,	NULL
W.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Thimmappaya	NULL
,	NULL
B.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
``	NULL
aB	NULL
n	NULL
m-	NULL
«	NULL
'hen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
1021-1030	NULL
synthesis	NULL
in	NULL
human	NULL
monocytes	NULL
is	NULL
,	NULL
distinctively	NULL
,	NULL
the	NULL
enhance-	NULL
=	NULL
97	NULL
ppong	NULL
,	NULL
S.	NULL
,	NULL
Brown	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Taffet	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17233-	NULL
ment	NULL
of	NULL
cytokine	NULL
mRNA	NULL
degradation	NULL
.	NULL

17239	NULL
28	NULL
.	NULL

29	NULL
.	NULL

80	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

IL-10	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
in	NULL
Human	NULL
Monocytes	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
L	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
182-185	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Liese	NULL
,	NULL
J.	NULL
,	NULL
Belohradsky	NULL
,	NULL
B.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Strobel	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6986-6993	NULL
Oeth	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
3772-3781	NULL
Eck	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Carr	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
6530-6536	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
A.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
34	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

9563	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tuomanen	NULL
,	NULL
E.	NULL
I.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
321-330	NULL
Gautam	NULL
,	NULL
S.	NULL
,	NULL
Tebo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Hamilton	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1725-1730	NULL
Zhou	NULL
,	NULL
Y.	NULL
,	NULL
Lin	NULL
,	NULL
G.	NULL
,	NULL
Baarsch	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Scamurra	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Murtaugh	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Leuk	NULL
.	NULL

Biol	NULL
.	NULL

56	NULL
,	NULL
507-513	NULL
Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Mizel	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
2424-2430	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Schutze	NULL
,	NULL
S.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Brunsing	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
8339-8343	NULL
Bomsztyk	NULL
,	NULL
K.	NULL
,	NULL
Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Iwasaki	NULL
,	NULL
T.	NULL
,	NULL
Rachie	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Hopkins	NULL
Sibley	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Regul	NULL
.	NULL

2	NULL
,	NULL
329-335	NULL
Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
854	NULL
,	NULL
395-398	NULL

